GlobalData on MSN11h
UK-based Verdiva launches with $410m and an oral GLP-1RA candidate
Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly ...
Le Lézard16h
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies
Verdiva Bio Limited ("Verdiva" or "the Company") today announced its launch as a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other ...
Novo, Eli Lilly to dominate global pharma sales in 2025: report
Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
BioPharma Dive8h
Verdiva starts up with $411M and a portfolio of obesity drugs from China
The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind ...
Outsourcing-pharma8h
Verdiva Bio launches with $411m in funds to advance oral and injectable drugs for obesity
Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...
Global Biotechnology Market Outlook 2025: Driving Growth At 13.0% CAGR Marketsandmarketstm
Browse in-depth TOC on " Global Biotechnology industry Outlook " 10 - Tables 20 - Figures 70 - Pages . The Global Biotech ...
Pronto Translations Announces Availability of Survey Results: Businesses Still Trust Human Translators Over AI for Sensitive Content
Pronto Translations today announced a new survey of businesses that examined preferences for translation services when ...